Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation

Heart Rhythm

Volumn 8, Issue 9, 2011, Pages 1436-1443

  Linz, Dominik ^a   Schotten, Ulrich ^b   Neuberger, Hans Ruprecht ^a   Böhm, Michael ^a   Wirth, Klaus ^c  

^a SAARLAND UNIVERSITY   (Germany)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Atrial electrophysiology parasympathetic activity; Atrial fibrillation; Cariporide; Glibenclamide; Obstructive sleep apnea

Indexed keywords

ATROPINE; CARIPORIDE; GLIBENCLAMIDE; POTASSIUM CHANNEL; SODIUM; URETHAN;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD GAS; BLOOD PRESSURE; CATHETER; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENDOTRACHEAL TUBE; HEART ATRIUM FIBRILLATION; HEART MUSCLE REFRACTORY PERIOD; HYPOXEMIA; MALE; NONHUMAN; OBSTRUCTIVE AIRWAY DISEASE; PRIORITY JOURNAL; SINUS RHYTHM; TRACHEA OBSTRUCTION; TRACHEA PRESSURE; VAGOTOMY; ANIMAL; ELECTROCARDIOGRAPHY; PATHOPHYSIOLOGY; PRESSURE; SLEEP APNEA SYNDROME; SWINE; TRACHEA; VAGUS NERVE;

ANIMALS; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; MALE; PRESSURE; SLEEP APNEA, OBSTRUCTIVE; SWINE; TRACHEA; VAGUS NERVE;

EID: 82455192038     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.03.053     Document Type: Article

References (24)

1. J ohnson KG, Johnson DC. Obstructive sleep apnea is a risk factor for stroke and atrial fibrillation. Chest 2010;138:239.
2. Gami AS, Pressman G, Caples SM, et al. A ssociation of atrial fibrillation and obstructive sleep apnea. Circulation 2004;110:364 -367.
3. Kasai T, Bradley TD. Obstructive sleep apnea and heart failure: Pathophysiologic and therapeutic implications. J Am Coll Cardiol 2011;57:119 -127.
4. J ongnarangsin K, Chugh A, Good E, et al. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2008;19:668-672.
5. Matiello M, Nadal M, Tamborero D, et al. Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnea patients. Europace 2010;2:1084- 1089.
6. Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003;107:2589 -2594.
7. 2- transient: An arrhythmia trigger within pulmonary veins. J Am Coll Cardiol 2006;47:1196 -1206.
8. Somers VK, Dyken ME, Mark AL, Abboud FM. Parasympathetic hyperresponsiveness and bradyarrhythmias during apnea in hypertension. Clin Auton Res 1992;2:171-176.
9. Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc 2004;79:1036 -1046.
10. Kohler M, Stradling Jr. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 2010;7:677- 685.
11. Van Wagoner DR. Mechanosensitive gating of atrial ATP-sensitive potassium channels. Circ Res 1993;72:973-983.
12. - exchange during ischaemia and reperfusion of normal and diabetic rat hearts. Cardiovasc Res 1990;24:873- 878.
13. Scholz W, Albus U, Counillon L, et al. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res 1995;29:260 -268.
14. Orban M, Bruce CJ, Pressman GS, et al. Dynamic changes of left ventricular performance and left atrial volume induced by the mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure. Am J Cardiol 2008;102:1557-1561.
15. Wirth KJ, Knobloch K. Differential effects of dofetilide, amiodarone, and class lc drugs on left and right atrial refractoriness and left atrial vulnerability in pigs. Naunyn Schmiedebergs Arch Pharmacol 2001;363:166 -174.
16. Stevenson IH, Roberts-Thomson KC, Kistler PM, et al. A trial electrophysiology is altered by acute hypercapnia but not hypoxemia: Implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart Rhythm 2010;7:1271-1272.
17. Lammers WJ, Kirchhof C, Bonke FI, Allessie MA. Vulnerability of rabbit atrium to reentry by hypoxia. Role of inhomogeneity in conduction and wavelength. Am J Physiol 1992;262:H47-55.
18. J ais P, Peng JT, Shah DC, et al. Left ventricular diastolic dysfunction in patients with so-called lone atrial fibrillation. J Cardiovasc Electrophysiol 2000;11:623- 625.
19. Choisy SCM, Arberry LA, Hancox JC, James AF. Increased susceptibility to atrial tachyarrhythmia in spontaneously hypertensive rat hearts. Hypertension 2010;49:498 -505.
20. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort. Circulation 1999;100:87-95.
21. Ghias M, Scherlag BJ, Lu Z, et al. The role of ganglionated plexi in apnearelated atrial fibrillation. J Am Coll Cardiol 2009;54:2075-2083.
22. J ayachandran JV, Zipes DP, Weksler J, Olgin JE. Role of the Na(+)/H(+) exchanger in short-term atrial electrophysiological remodeling. Circulation 2000;101:1861-1866.
23. Wijffels MC, Kirchhof CJ, Dorland R, Power J, Allessie MA. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: Roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 1997;96:3710 -3720.
24. Fabiani ME, Story DF. Effects of cromakalim, pinacidil and glibenclamide on cholinergic transmission in rat isolated atria. Pharmacol Res 1995;32: 155-163.